ENGELMAN JA, WONG KK and MEYERSON M, affiliated with Harvard Medical School, collaborate on research focused on developing effective strategies for the treatment of EGFR-mutated LC (42, 44, 52, 59, 65, 67). This evidence concerns the gene EGFR and laryngotracheoesophageal cleft.